Literature DB >> 15866251

Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study.

Lars Frost1, Lone Juul Hune, Peter Vestergaard.   

Abstract

PURPOSE: We examined the association between the body mass index analyzed as a continuous variable and by categorization according to World Health Organization criteria (normal weight, overweight and obesity) and the risk of a hospital (inpatient as well as outpatient) diagnosis of atrial fibrillation or flutter.
METHODS: Population-based prospective cohort study conducted from December 1993 to December 2001 among 47589 participants (22482 men and 25107 women) without preexisting cardiovascular or endocrine disease and with a mean age at baseline of 56 years (range 50-64 years) in the Danish Diet, Cancer, and Health Study. Subjects were followed up in the Danish National Registry of Patients and in the Danish Civil Registration System.
RESULTS: During follow-up (mean, 5.7 years) atrial fibrillation or flutter developed in 553 subjects (372 men and 181 women). The adjusted hazard ratio for atrial fibrillation or flutter per unit of increase in the body mass index was 1.08 (95% confidence interval [CI]: 1.05 to 1.11) in men and 1.06 (95% CI: 1.03 to 1.09) in women. When using normal weight as a reference, the adjusted hazard ratio for atrial fibrillation or flutter by overweight was 1.75 (95% CI: 1.35 to 2.27) in men and 1.39 (95% CI: 0.99 to 1.94) in women. The adjusted hazard ratio by obesity was 2.35 (95% CI: 1.70 to 3.25) in men and 1.99 (95% CI: 1.31 to 3.02) in women.
CONCLUSION: Overweight and obesity are associated with an increased risk of a diagnosis of atrial fibrillation or flutter.

Entities:  

Mesh:

Year:  2005        PMID: 15866251     DOI: 10.1016/j.amjmed.2005.01.031

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  122 in total

1.  Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study.

Authors:  Rachel R Huxley; Alvaro Alonso; Faye L Lopez; Kristian B Filion; Sunil K Agarwal; Laura R Loehr; Elsayed Z Soliman; James S Pankow; Elizabeth Selvin
Journal:  Heart       Date:  2011-09-19       Impact factor: 5.994

2.  Assessment of atrial conduction time by tissue Doppler echocardiography and P-wave dispersion in smokers.

Authors:  Erdal Akturk; Jülide Yağmur; Nusret Açıkgöz; Necip Ermiş; Mehmet Cansel; Yasin Karakuş; Hakan Taşolar; Ferhat Eyupkoca; Hasan Pekdemir
Journal:  J Interv Card Electrophysiol       Date:  2012-03-06       Impact factor: 1.900

3.  Obesity begets atrial fibrillation: a contemporary summary.

Authors:  Jared W Magnani; Elaine M Hylek; Caroline M Apovian
Journal:  Circulation       Date:  2013-07-23       Impact factor: 29.690

4.  Anthropometric parameters and the incidence of atrial fibrillation in older people: the PRO.V.A study.

Authors:  Caterina Trevisan; Stefania Maggi; Chiara Curreri; Giovanni Nante; Marianna Noale; Marina De Rui; Egle Perissinotto; Leonardo Sartori; Sabina Zambon; Gaetano Crepaldi; Enzo Manzato; Giuseppe Sergi
Journal:  Clin Cardiol       Date:  2017-02-13       Impact factor: 2.882

Review 5.  Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation.

Authors:  Rachel R Huxley; Kristian B Filion; Suma Konety; Alvaro Alonso
Journal:  Am J Cardiol       Date:  2011-04-27       Impact factor: 2.778

6.  Classification, Etiology and Clinical Evaluation of Atrial Fibrillation.

Authors:  Ermengol Valles; Francis E Marchlinski
Journal:  J Atr Fibrillation       Date:  2008-05-16

Review 7.  European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Authors:  Bulent Gorenek; Antonio Pelliccia; Emelia J Benjamin; Giuseppe Boriani; Harry J Crijns; Richard I Fogel; Isabelle C Van Gelder; Martin Halle; Gulmira Kudaiberdieva; Deirdre A Lane; Torben Bjerregaard Larsen; Gregory Y H Lip; Maja-Lisa Løchen; Francisco Marin; Josef Niebauer; Prashanthan Sanders; Lale Tokgozoglu; Marc A Vos; David R Van Wagoner; Laurent Fauchier; Irina Savelieva; Andreas Goette; Stefan Agewall; Chern-En Chiang; Márcio Figueiredo; Martin Stiles; Timm Dickfeld; Kristen Patton; Massimo Piepoli; Ugo Corra; Pedro Manuel Marques-Vidal; Pompilio Faggiano; Jean-Paul Schmid; Ana Abreu
Journal:  Eur J Prev Cardiol       Date:  2016-11-04       Impact factor: 7.804

8.  Usefulness of pharmacologic conversion of atrial fibrillation during dofetilide loading without the need for electrical cardioversion to predict durable response to therapy.

Authors:  Rohit Malhotra; Kenneth C Bilchick; John P DiMarco
Journal:  Am J Cardiol       Date:  2013-11-09       Impact factor: 2.778

9.  Associations of obesity and body fat distribution with incident atrial fibrillation in the biracial health aging and body composition cohort of older adults.

Authors:  Konstantinos N Aronis; Na Wang; Caroline L Phillips; Emelia J Benjamin; Gregory M Marcus; Anne B Newman; Nicolas Rodondi; Suzanne Satterfield; Tamara B Harris; Jared W Magnani
Journal:  Am Heart J       Date:  2015-06-14       Impact factor: 4.749

10.  Body fat, body fat distribution, lean body mass and atrial fibrillation and flutter. A Danish cohort study.

Authors:  Lars Frost; Emelia J Benjamin; Morten Fenger-Grøn; Asger Pedersen; Anne Tjønneland; Kim Overvad
Journal:  Obesity (Silver Spring)       Date:  2014-02-18       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.